<qa>  Evidence of clinically significant cardiovascular, hepatic, gastrointestinal, renal, respiratory,- Evidence of clinically significant cardiovascular, hepatic, gastrointestinal, renal, respiratory, endocrine, hematologic, neurologic, or psychiatric disease or abnormalities or a known history of any gastrointestinal surgery that could impact PK of the study drug 